Skip to main content
. Author manuscript; available in PMC: 2014 Apr 29.
Published in final edited form as: Clin Sci (Lond). 2012 Jun;122(11):535–543. doi: 10.1042/CS20110523

Figure 4. Cox-1 and Cox-2 inhibition decreased the maximal response to noradrenaline only in IgG-treated-SHR mesenteric arteries.

Figure 4

Emax to noradrenaline in the absence (white bars) or presence of (A) SC-560 (Cox-1 inhibitor) or (B) NS-398 (Cox-2 inhibitor) (black bars) in mesenteric resistance arteries from Wistar and SHR treated with IgG or anti-TLR4. *P< 0.05 vs. SHR IgG NA. Statistical test: one-way ANOVA.